Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Charles River Labs Acquires Distributed Bio | Contract Pharma

What are you searching for?

Sign in
Breaking News

Charles River Labs Acquires Distributed Bio

Establishes integrated, large molecule discovery platform.

By: Contract Pharma

Contract Pharma Staff

Charles River Laboratories has acquired Distributed Bio, Inc. for $83 million in cash, subject to customary closing adjustments. The acquisition marks the culmination of an exclusive partnership between the companies initiated in October 2018.
 
Based in South San Francisco, CA, Distributed Bio is a next-gen antibody discovery company. Its SuperHuman antibody libraries and integrated antibody optimization technologies help to enhance the probability of success for delivering high-quality, readily formattable antibody fragments to support antibody and cell and gene therapy candidates.
 
This large molecule discovery platform improves the chance of successful hit finding, reduces optimization requirements, and as a result expedites the antibody discovery process by several months. Distributed Bio’s computational immunology expertise also enables optimization of existing client antibodies generated through more traditional platforms, such as hybridoma or traditional phage display.
 
The acquisition expands Charles River’s scientific capabilities with an innovative, large-molecule discovery platform. The transaction combines Distributed Bio’s antibody libraries and immuno-engineering platform with Charles River’s extensive drug discovery and non-clinical development expertise to create an integrated, end-to-end platform for therapeutic antibody and cell and gene therapy discovery and development.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics